Nevanac 3 mg / ml, Augentropfensuspension

7680657110012 CH-65711 Augentropfensuspension
Nevanac 3 mg / ml, Augentropfensuspension
Nevanac 3 mg / ml, Augentropfensuspension
Nevanac 3 mg / ml, Augentropfensuspension
1 / 3
google

Article details

Package size
3
Selling units
3
Measure
ml
Galenic form
Augentropfensuspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/03/2025
Patient information leaflet
Français
28/03/2025
Patient information leaflet
Italien
28/03/2025
Summary of Product Characteristics
Allemand
28/10/2021
Summary of Product Characteristics
Français
28/10/2021
Summary of Product Characteristics
Italien
28/10/2021

Detailed composition

Substance Quantity Type Category
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
0.05 MG Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 30.25
Specialties list
Yes
Generic
No
SL addition date: 01/05/2018

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
65711
Drug name
Nevanac 3 mg / ml, Augentropfensuspension
Galenic form
AUGN
ATC Code
S01BC10
Authorization status
Z
Dispensing category
B
First authorization
05/08/2016
Authorization expiration date
31/12/9999
IT Number
11.06.3.
Domain
Human medicine
Field of application
Nicht-steroidaler Entzündungshemmer zur Applikation am Auge

Package details

Description (FR)
NEVANAC susp opht 3 mg/ml fl 3 ml
Description (DE)
NEVANAC Susp Opht 3 mg/ml Fl 3 ml
Market launch
05/08/2016
Narcotic (BTM)
No